Olivier Dewit

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 633 citations

Inflammation, Anti-inflammatory, Gastroenterology +4

Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4

Cécile Libioulle, Édouard Louis, Sarah Hansoul et al. · PLoS Genetics · 2007 · 560 citations · Full text

Genome-wide Association Maps, Disease Etiology, Gene Desert +20

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Brian G. Feagan, William J. Sandborn, Geert D’Haens et al. · The Lancet · 2017 · 435 citations · Full text

Inflammation, Rheumatology, Placebo-controlled Phase 2 +8

The impact of interface usability on trust in Web retailers

Marie Christine Roy, Olivier Dewit, Benoit A. Aubert · Internet Research · 2001 · 391 citations

Customer Satisfaction, Consumer Research, Communication +18

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn’s Disease After Ileocolonic Resection

Miguel Regueiro, Brian G. Feagan, Bin Zou et al. · Gastroenterology · 2016 · 320 citations · Full text